117 related articles for article (PubMed ID: 37924792)
1. Preparation and characterization of solid lipid nanoparticles encapsulated noscapine and evaluation of its protective effects against imiquimod-induced psoriasis-like skin lesions.
Rahmanian-Devin P; Askari VR; Sanei-Far Z; Baradaran Rahimi V; Kamali H; Jaafari MR; Golmohammadzadeh S
Biomed Pharmacother; 2023 Dec; 168():115823. PubMed ID: 37924792
[TBL] [Abstract][Full Text] [Related]
2. Topical Formulation of Noscapine, a Benzylisoquinoline Alkaloid, Ameliorates Imiquimod-Induced Psoriasis-Like Skin Lesions.
Nourbakhsh F; Mousavi SH; Rahmanian-Devin P; Baradaran Rahimi V; Rakhshandeh H; Askari VR
Evid Based Complement Alternat Med; 2022; 2022():3707647. PubMed ID: 35497929
[TBL] [Abstract][Full Text] [Related]
3. A promising impact of oral administration of noscapine against imiquimod-induced psoriasis-like skin lesions.
Nourbakhsh F; Mousavi SH; Rahmanian-Devin P; Baradaran Rahimi V; Rakhshandeh H; Askari VR
Avicenna J Phytomed; 2023; 13(4):412-428. PubMed ID: 37663384
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies.
Agrawal YO; Mahajan UB; Mahajan HS; Ojha S
Int J Nanomedicine; 2020; 15():4763-4778. PubMed ID: 32753865
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studies.
Hseu JH; Chan CI; Vadivalagan C; Chen SJ; Yen HR; Hseu YC; Yang HL; Wu PY
Biomed Pharmacother; 2023 Oct; 166():115307. PubMed ID: 37573659
[TBL] [Abstract][Full Text] [Related]
6. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
[TBL] [Abstract][Full Text] [Related]
7. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
Zhao K; Pu S; Sun L; Zhou D
Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802
[TBL] [Abstract][Full Text] [Related]
8. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
9. Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells.
Madan J; Pandey RS; Jain V; Katare OP; Chandra R; Katyal A
Nanomedicine; 2013 May; 9(4):492-503. PubMed ID: 23117045
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrin-Modified CeO
Wu L; Liu G; Wang W; Liu R; Liao L; Cheng N; Li W; Zhang W; Ding D
Int J Nanomedicine; 2020; 15():2515-2527. PubMed ID: 32368038
[TBL] [Abstract][Full Text] [Related]
11. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod-induced skin inflammation is relieved by knockdown of sodium channel Na
Zhao J; Xie P; Galiano RD; Qi S; Mao R; Mustoe TA; Hong SJ
Exp Dermatol; 2019 May; 28(5):576-584. PubMed ID: 30903711
[TBL] [Abstract][Full Text] [Related]
13. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment.
Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV
Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227
[TBL] [Abstract][Full Text] [Related]
14. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study.
Arora R; Katiyar SS; Kushwah V; Jain S
Expert Opin Drug Deliv; 2017 Feb; 14(2):165-177. PubMed ID: 27882780
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
Chamcheu JC; Siddiqui IA; Adhami VM; Esnault S; Bharali DJ; Babatunde AS; Adame S; Massey RJ; Wood GS; Longley BJ; Mousa SA; Mukhtar H
Int J Nanomedicine; 2018; 13():4189-4206. PubMed ID: 30057446
[TBL] [Abstract][Full Text] [Related]
17. Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent.
Parmar KM; Jagtap CS; Katare NT; Dhobi M; Prasad SK
Indian J Pharmacol; 2021; 53(2):125-131. PubMed ID: 34100396
[TBL] [Abstract][Full Text] [Related]
18. Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice.
Pukale SS; Sharma S; Dalela M; Singh AK; Mohanty S; Mittal A; Chitkara D
Acta Biomater; 2020 Oct; 115():393-409. PubMed ID: 32846238
[TBL] [Abstract][Full Text] [Related]
19. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
[TBL] [Abstract][Full Text] [Related]
20. Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.
Qin S; Wen J; Bai XC; Chen TY; Zheng RC; Zhou GB; Ma J; Feng JY; Zhong BL; Li YM
Mol Med Rep; 2014 Jun; 9(6):2097-104. PubMed ID: 24718773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
